Gastrointestinal Cancer diagnosis and treatment in China and Global Market Trend Discussion. Are you ready?
- Gastrointestinal (stomach) Cancer diagnosis
- Global and China gastrointestinal cancer EPI and leading key product sales
- Global and Chinese diagnostic leaders in the Gastrointestinal cancer diagnosis
- Global and Chinese therapeutic leaders in the Gastrointestinal cancer treatment
- Global innovative diagnostic trend
Event details
|
DATE Wednesday January 8, 2020 VENUE Webex TIME 4:00 PM - 5:00 PM RSVP This is a FREE event VIP tckets priority for Lingmed current clients Please RSVP by January 7, 2020 |
PRESENTERS Lingling Cao, CEO & Founder Hank Wang, Medical advisor REGISTER +86 21 5386 3003 |
Agenda
| 16:00 - 16:10 | Linkedbio services & projects introductions | by LingLing Cao |
| 16:10 - 16:45 | Gastrointestinal Cancer diagnosis and treatment in China and Global Market Trend Discussion. | by Hank Wang |
| 16:45 - 16:55 | Panel discussions | |
| 16:55 - 17:00 | Q&A |
Presenters
 |
Lingling Cao CEO & Founder Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany |
 |
Hank Wang Medical advisor Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market |